Baijin Life Science Director Resigns, Triggering Temporary Governance Non-Compliance

Affluent Partners Holdings ( (HK:1466) ) has issued an announcement.

Baijin Life Science Holdings has announced the resignation of independent non-executive director (INED) Mr. Lee Ka Leung Daniel, who has also stepped down as chairman of the audit committee and as a member of the remuneration and nomination committees, effective 27 January 2026, citing personal reasons and confirming no disagreement with the board. His departure leaves the company temporarily in breach of several Hong Kong Listing Rules regarding the required number and proportion of INEDs and the composition of the audit, remuneration and nomination committees, prompting Baijin to initiate a search for a replacement INED and new committee members while appointing existing INED Mr. Wong Siu Keung Joe as the new chairman of the audit committee, a move that underscores both a near-term governance gap and the board’s efforts to restore full regulatory compliance.

The most recent analyst rating on (HK:1466) stock is a Sell with a HK$0.58 price target. To see the full list of analyst forecasts on Affluent Partners Holdings stock, see the HK:1466 Stock Forecast page.

More about Affluent Partners Holdings

Baijin Life Science Holdings Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange under stock code 1466. It operates with a board structure that includes executive, non-executive and independent non-executive directors, supported by key governance committees such as the audit, remuneration and nomination committees to meet Hong Kong listing compliance requirements.

Average Trading Volume: 400,003

Technical Sentiment Signal: Sell

Current Market Cap: HK$512.7M

For detailed information about 1466 stock, go to TipRanks’ Stock Analysis page.